This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diez-Itza, I. Articles by Lopez-Otin, C. Search for Related Content PubMed PubMed Citation Articles by Diez-Itza, I. Articles by Lopez-Otin, C.

American Journal of Pathology, Vol 144, 310-320, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression and prognostic significance of apolipoprotein D in breast cancer

I Diez-Itza, F Vizoso, AM Merino, LM Sanchez, J Tolivia, J Fernandez, A Ruibal and C Lopez-Otin
Departamento de Biologia Functional, Facultad de Medicina, Universidad de Oviedo, Spain.

Apolipoprotein D (apo D) is a glycoprotein involved in the human plasma lipid transport system and present at large amounts in cyst fluid from women with gross cystic disease of the breast. Apo D expression in breast carcinomas was examined by immunoperoxidase staining of a series of 163 tumors. A total of 60 (36.8%) tumors were negative for apo D immunostaining, 28 (17.2%) carcinomas were weakly positive, 33 (20.2%) were moderately stained, whereas the remaining 42 (25.8%) tumors were strongly stained with the specific antibodies. No significant correlation was found between apo D content and tumor size, lymph node involvement, or biochemical parameters such as estrogen receptors, cathepsin D, or pS2 protein. However, the finding of a significant association between apo D and menopausal status of patients or differentiation grade of tumors, with apo D values being lower in tumors from premenopausal women or in poorly differentiated carcinomas, suggested a potential value of this glycoprotein as a prognostic factor in breast cancer. Preliminary analysis of relapse-free survival and overall survival in a subgroup of 152 women with a mean follow-up of 42 months confirmed that low apo D values were significantly associated to a shorter relapse-free survival and poorer survival. According to these data, we propose that apo D in combination with other well-established prognostic factors may contribute to more accurately identify subgroups of breast cancer patients with low or high risk for relapse and death.

This article has been cited by other articles:

				S. B. Hunter, V. Varma, B. Shehata, J.D.L. Nolen, C. Cohen, J. J. Olson, and C.-Y. Ou Apolipoprotein D Expression in Primary Brain Tumors: Analysis by Quantitative RT-PCR in Formalin-fixed, Paraffin-embedded Tissue J. Histochem. Cytochem., August 1, 2005; 53(8): 963 - 969. [Abstract] [Full Text] [PDF]

				H. Alexander, A. L. Stegner, C. Wagner-Mann, G. C. Du Bois, S. Alexander, and E. R. Sauter Proteomic Analysis to Identify Breast Cancer Biomarkers in Nipple Aspirate Fluid Clin. Cancer Res., November 15, 2004; 10(22): 7500 - 7510. [Abstract] [Full Text] [PDF]

				W. C.Y. Leung, A. Lawrie, S. Demaries, H. Massaeli, A. Burry, S. Yablonsky, J. M. Sarjeant, E. Fera, E. Rassart, J. G. Pickering, et al. Apolipoprotein D and Platelet-Derived Growth Factor-BB Synergism Mediates Vascular Smooth Muscle Cell Migration Circ. Res., July 23, 2004; 95(2): 179 - 186. [Abstract] [Full Text] [PDF]

				J. M. Sarjeant, A. Lawrie, C. Kinnear, S. Yablonsky, W. Leung, H. Massaeli, W. Prichett, J. P. Veinot, E. Rassart, and M. Rabinovitch Apolipoprotein D Inhibits Platelet-Derived Growth Factor-BB-Induced Vascular Smooth Muscle Cell Proliferated by Preventing Translocation of Phosphorylated Extracellular Signal Regulated Kinase 1/2 to the Nucleus Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2172 - 2177. [Abstract] [Full Text] [PDF]

				E. del Valle, A. Navarro, A. Astudillo, and J. Tolivia Apolipoprotein D Expression in Human Brain Reactive Astrocytes J. Histochem. Cytochem., October 1, 2003; 51(10): 1285 - 1290. [Abstract] [Full Text] [PDF]

				D. Porter, J. Lahti-Domenici, A. Keshaviah, Y. K. Bae, P. Argani, J. Marks, A. Richardson, A. Cooper, R. Strausberg, G. J. Riggins, et al. Molecular Markers in Ductal Carcinoma in Situ of the Breast Mol. Cancer Res., March 1, 2003; 1(5): 362 - 375. [Abstract] [Full Text] [PDF]

				S. Do Carmo, D. Seguin, R. Milne, and E. Rassart Modulation of Apolipoprotein D and Apolipoprotein E mRNA Expression by Growth Arrest and Identification of Key Elements in the Promoter J. Biol. Chem., February 8, 2002; 277(7): 5514 - 5523. [Abstract] [Full Text] [PDF]

				F. Vizoso, E. Plaza, J. Vazquez, C. Serra, M. L. Lamelas, L. O. Gonzalez, A. M. Merino, and J. Mendez Lysozyme Expression by Breast Carcinomas, Correlation With Clinicopathologic Parameters, and Prognostic Significance Ann. Surg. Oncol., September 1, 2001; 8(8): 667 - 674. [Abstract] [Full Text] [PDF]

				D. C. Sgroi, S. Teng, G. Robinson, R. LeVangie, J. R. Hudson Jr., and A. G. Elkahloun In Vivo Gene Expression Profile Analysis of Human Breast Cancer Progression Cancer Res., November 1, 1999; 59(22): 5656 - 5661. [Abstract] [Full Text] [PDF]

				C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]

				Y. S. Lopez-Boado, M. Klaus, M. I. Dawson, and C. Lopez-Otin Retinoic Acid-induced Expression of Apolipoprotein D and Concomitant Growth Arrest in Human Breast Cancer Cells Are Mediated through a Retinoic Acid Receptor RARalpha -dependent Signaling Pathway J. Biol. Chem., December 13, 1996; 271(50): 32105 - 32111. [Abstract] [Full Text] [PDF]